Howard Rutman

Company: Xalud Therapeutics

Job title: Chief Medical Officer

Seminars:

Translating A Non-Viral Anti-Inflammatory Gene Therapy into ALS Mouse Models & Preparing for First In-Human Studies 1:10 pm

Developing a unique therapeutic approach of targeting IL-10 with a non-viral gene therapy Showcasing preclinical data of anti-inflammatory effect in TDP-43 mouse models Outlining future directions for translation into phase 1 clinical studyRead more

day: Day Two Track A PM